Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance. - Wikidata - awgldk - TriplyDB

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

http://www.wikidata.org/entity/Q37115920

about

Tiotropium versus placebo for chronic obstructive pulmonary disease Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Tiotropium versus placebo for chronic obstructive pulmonary disease Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Breathlessness with pulmonary metastases: a multimodal approach.Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data.Value and usability of unpublished data sources for systematic reviews and network meta-analyses.Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials Impact of bronchodilator therapy on exercise tolerance in COPD.Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.Tiotropium HandiHaler in the treatment of COPD: a safety review Pharmacological treatment of COPD.Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.Exercise for patients with COPD: an integral yet underutilized intervention.Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression.Long-acting muscarinic antagonists.Tiotropium formulations and safety: a network meta-analysis Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology

P2860

Q24194833-3C0DCD69-72E6-47D4-8DD6-5DF705C8E368 Q24197853-57520BA7-9452-4152-8C4B-56943926917E Q24202175-1F877406-9697-4D06-ABD4-9878A9C36393 Q26765425-5087F5FE-A458-48A4-A3A1-FD0249DDB6BF Q28079883-EC0D8FA3-836E-489B-B7D8-3AC059635A8D Q30620671-2ADAB6CD-A1B2-4BC1-A8CD-4BDF51B95502 Q30836872-6D1F4C61-025A-4835-9AB0-7915A0981666 Q30949429-D6E2DD95-5F61-4B5B-864B-77CDAC214164 Q31133808-E5074C4D-72BB-436C-99CA-8BF527F4A0AE Q33824534-092E1C97-039D-40B7-8208-6C7A6C1D85C2 Q33831434-296278B0-8025-4C50-AB67-A5B3D990C3D3 Q34944616-EFDB0250-6CAD-4953-BB7E-FB8B1D0D7717 Q35225129-479FFAC4-496D-4CA8-B629-49AFF05C62B2 Q37474538-AC0D3316-E3BD-409D-B0A7-1A07A96FFEDC Q37924598-83F839A7-FD35-4171-8694-11FBF46CC81F Q37973132-6BD4F7D3-04E2-4740-B8C6-44102ABEB542 Q38085131-676BBB9A-4121-44EF-951A-ABCEA6156300 Q38317463-C2E5C608-B92A-4A77-B4D3-B959CF43F75F Q38537326-E455D170-E642-45DD-9B95-80CF8C8AAD71 Q39137733-37FC9748-F02D-494B-ADB8-40F4668E1782 Q57817177-A1CCC24D-4A92-43DA-8E7B-91EAD45C8DAC Q58759101-52B29D7C-EBEE-4E9F-B494-F93F56E0AD6F

P2860

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

http://www.wikidata.org/entity/Q37115920

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@en

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@nl

type

label

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@en

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@nl

prefLabel

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@en

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@nl

P1433

Q37115920-29095B4D-4AD5-4116-8874-702BD42EB9C3

P1476

Q37115920-9572AC0F-BD9C-4B48-A07D-33BB5136E0D9

P2093

Q37115920-10B24FBA-7765-40EB-A21C-1DCE76B66270

Q37115920-310786F3-CCFC-4DE7-8940-A8897605C5F7

Q37115920-9FF535E4-F383-436A-8961-1DEBB9309040

Q37115920-C13D8C1C-3A35-4491-806F-3DF7A3718E26

Q37115920-E2A9E917-397A-4660-9247-AF7E78C1EB59

Q37115920-E940369F-55CF-4893-BDAF-7119751D6521

Q37115920-FB5CC453-C924-4C66-8041-7A9DCB4ECCBC

P2860

Q37115920-30A55F60-7E5C-45B3-BD8B-29AC5E0BE073

Q37115920-3805B3FF-5BE4-44B3-922E-8BA9B373E190

Q37115920-387BFC77-60CB-4196-A8B2-CCE2B7246667

Q37115920-47BE1F9B-6687-4FF3-838C-956542194780

Q37115920-48790042-63B9-446F-B698-CF72CC35F229

Q37115920-68BDC83E-DB6E-4108-9E02-64C166A75EF0

Q37115920-7727B06B-8B01-483C-8D94-22C694AA7434

Q37115920-8BFD6477-FC07-438A-BFAB-34A259AAD57C

Q37115920-9F5A343C-6182-4D07-B9B8-F7CCF0D23DB1

Q37115920-A1D78610-7E80-46F2-84FE-6FF8672FE654

P304

Q37115920-CBFC512D-C5E8-46DA-B5F4-247AD77C4C0F

P31

Q37115920-57E49198-DC30-4B04-B504-A36F224200A8

P356

Q37115920-D3F0B58D-5583-45B0-ABC5-9ACD3C0BFE84

P407

Q37115920-0C37C7D3-197E-49FB-9D0F-5CD68EE640A7

P433

Q37115920-08D4743E-5EA9-4EE3-AF96-DF7D6C8D9617

P478

Q37115920-6BF7CCA6-6B04-4F0D-AA2A-2DCC2EE2942D

P577

Q37115920-A1F604EA-83AA-421F-892D-078FEE7BECA5

P698

Q37115920-2CD997D3-84A0-494C-95DF-1B24242007C1

P921

Q37115920-2A8B0D0D-B263-4375-A3DA-CF6CA98A965F

P932

Q37115920-DD3AA5D4-0D96-42F3-A02A-FB73498F6F03

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Tiotropium and exercise traini ...... yspnea and exercise tolerance.

@en

P2093

Gianni Balzano

http://www.w3.org/2001/XMLSchema#string

Katia Foglio

http://www.w3.org/2001/XMLSchema#string

Nicolino Ambrosino

http://www.w3.org/2001/XMLSchema#string

Patrizia Lessi

http://www.w3.org/2001/XMLSchema#string

Pier Luigi Paggiaro

http://www.w3.org/2001/XMLSchema#string

Steven Kesten

http://www.w3.org/2001/XMLSchema#string

Tiotropium Multicentric Italian Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of Spirometry, 1994 Update. American Thoracic Society

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Psychophysical bases of perceived exertion

Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction.

ATS statement: guidelines for the six-minute walk test.

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients.

Global burden of COPD: risk factors, prevalence, and future trends.

P304

771-780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S3935

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19281092

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

2650608

http://www.w3.org/2001/XMLSchema#string